Alvotech Makes Multiple Moves As It Allies With Advanz For Five European Biosimilars
Firm Also Drops Products From Stada Deal And Reveals A Pair Of New Pipeline Products
In a busy week for Alvotech, the firm has announced an expansion of its partnership with Advanz to cover five further European biosimilars, at the same time as revealing two new pipeline assets. Meanwhile, the company has also dropped three products from an existing European partnership with Stada and has also terminated a development deal with BiosanaPharma.
